The deficit syndrome of schizophrenia: Towards heterogeneity

Psychopathology

Volumn 30, Issue 5, 1997, Pages 257-262

  Thibaut, F ^a   Petit, M ^a  

^a CHS du Rouvray   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CULTURAL DEPRIVATION; DISEASE CLASSIFICATION; HUMAN; NEGATIVE SYNDROME; REVIEW; SCHIZOPHRENIA;

EID: 0030778279     PISSN: 02544962     EISSN: None     Source Type: Journal    
DOI: 10.1159/000285057     Document Type: Article

References (53)

1. Bleuler E: Dementia praecox ou groupe des schizophrénies: transi A Viallard. Ecole Lacanicnnc de Psychanalyse. Paris, 1993.
2. Kraepelin E: Der psychologischc Vcrsuch in der Psychiatrie. Psychol Arb 1896:1.
3. e session. Paris. Masson. 1926.
4. er Congrès mondial de psychiatrie. Paris. Masson, 1950.
5. Golgberg TE, Weinberger DR: A case against subtyping in schizophrenia. Schizophr Res 1995:17:147-152.
6. Murray RM. Lewis S, Reveley AM: Towards an actiological classification of schizophrenia. Lancet 1985;vol i: 1023-1026.
7. Tsuang MT. Faraone SV: The case for heterogeneity in the etiology of schizophrenia. Schizophr Res 1995; 17: 161-175.
8. Cardno AG. Farmer AE: The case for or against heterogeneity in the etiology of schizophrenia: The genetic evidence. Schizophr Res 1995; 17:153-159.
9. Tsuang MT. Winokur G: Criteria for subtyping schizophrenia. Arch Gen Psychiatry 1974:31:43.
10. Kendlcr KS, Gruenberg AM. Tsuang MT: Outcome of schizophrenic subtypes defined by four diagnostic systems. Arch Gen Psychiatry 1984;41:149-154.
11. Farmer AE. McGuffin P. Spitznagel EL: Heterogeneity in schizophrenia: A cluster-analvtic approach. Psychiatry Res 1983:8:1-12.
12. Delay J, Denikcr P: Méthodes chimiothérapiques en psychiatrie. Paris. Masson, 1961.
13. Strauss JS. Carpenter WT. Bartko JJ: The diagnosis and understanding of schizophrenia. Part III: Speculations on the processes that underlie schizophrenic symptoms and signs. Schizophr Bull 1974:11:61-75.
14. Crow TJ: Molecular pathology of schizophrenia: More than one disease process? BMJ 1980:280:66-68.
15. Lewis SW: Computerised tomography in schizophrenia 15 years on. Br J Psychiatry 1990:157:16-24.
16. Daniel DG. Goldberg TE, Gibbon R. Weinberger DR: Lack of a bimodal distribution of ventricular size in schizophrenia: A gaussian mixture analysis of 1056 cases and controls. Biol Psychiatry 1991:30:887-903.
17. Crow TJ: The two-syndrome concept: Origins and current status. Schizophr Bull 1985:11:471-486.
18. Andrcascn NC. Olsen S: Negative vs positive schizophrenia. Arch Gen Psychiatry 1982:39:789-794.
19. Kay SR. Fiszbein A, Opler LA: The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-276.
20. Kay SR, Opler LA: Deficit or negative syndrome? Am J Psychiatry 1989:149:282-283.
21. De Bonis M, Boek P, Lebaux MO: Methodological problems in subtyping schizophrenics: Correlations versus hierarchical relationships. Psychiatry' Psychobiol 1987:2:425-437.
22. Liddle PF: Syndromes of schizophrenia on factor analysis (correspondence). Br J Psychiatry' 1992:161:861.
23. Dollfus S. Evcritt B. Ribeyre JM, Assouly-Besse F, Sharp C, Petit M: Identifying subtypes of schizophrenia by cluster analysis. Schizophr Bull 1996:22:545-555.
24. Kendlcr KS. Gruenberg AM. Tsuang MT: Subtype stabilitv in schizophrenia. Am J Psvchiatrv 1985:142:827-832.
25. Marneras A. Deister A, Rhode A: Validity of the negative/posilive dichotomy for schizophrenic disorders under long-term conditions. Schizophr Res 1992:7:117-123.
26. Carpenter WT. Heinrichs DW. Wagntan AMI: Deficit and nondeficit forms of schizophrenia: The concept. Am J Psychiatry 1988;145:578-583.
27. Fenton WS. McGlashan TH: Testing systems for assessment of negative symptoms in schizophrenia. Arch Gen Psychiatry 1992:49:179-182.
28. Amador XF. Kirkpatrick B, Carpenter WT, Yale SA, Marcinko L: The long-term stability of the deficit syndrome. Schizophr Res 1996; 18:116.
29. Minkowski E: La schizophrenic. Paris. Payot. 1927.
30. Guiraud P: Psychiatrie clinique. Paris. Le François. 1956.
31. Delay J: Les dérèglements de l'humeur. Paris. PUF. 1946, p 179.
32. Kirkpatrick B, Buchanan RW, McKenney PD, Alphs LD, Carpenter WT: The schedule for the deficit syndrome: An instrument for research in schizophrenia. Psychiatry Res 1989:30:119-123.
33. Widlôchcr DJ: Psychomotor retardation: Clinical, theoretical, and psychometric aspects. Psychiatr Clin North Am 1983:6:27-40.
34. Langlois S. Lesieur Ph. Dollfus S. Petit M: Comparaison de 2 échelles d'évaluation de la symptomatologie dépressive chez, des patients schizophrènes. Encéphale 1995:20:487-493.
35. Carpenter WT: The deficit syndrome. Am J Psychiatry 1994; 151:327-329.
36. Kirkpatrick B. Buchanan RW: Anhedonia and the deficit syndrome of schizophrenia. Psychiatry Res 1990:31: 25-30.
37. Fenton WS. McGlashan TH: Antecedents, symptom progression and long-term outcome of the deficit syndrome of schizophrenia. Am J Psychiatry 1994;151:351-356.
38. Kirkpatrick B. Amador XF, Flaunt M. Yale SA. Gorman JM. Carpenter WT. Tohcn M. McGlashan TH: The deficit syndrome in the DSM-IV field trials: I. Alcohol and other drug abuse. Schizophr 1996:20:69-77.
39. Kirkpatrick B. Amador XF. Yale SA. Bustello JR. Buchanan RW. Tohen M: The deficit syndrome in the DSM-IV field trial. Part II. Depressive episodes and persecutory beliefs. Schizophr Res 1996:20:79-90.
40. Buchanan RW, Kirkpatrick B. Heinrichs DW, Carpenter WT: Clinical correlates of the deficit syndrome of schizophrenia. Am J Psychiatry 1990:147:290-294.
41. Wagman AMI, Heinrichs DW. Carpenter WT: The deficit and nondeficit forms of schizophrenia. Neuropsychological evaluation. Psychiatry Res 1987:22:319-330.
42. Tamminga C. Thaker G. Buchanan RW, Kirkpatrick B. Alphs LD. Chase TN: Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch Gen Psychiatry 1992:49:522-530.
43. Buchanan RW. Brcier A. Kirkpatrick B. Elkashef A, Munson RC. Gcllad F, Carpenter WT: Structural abnormalities in deficit and nondeficit schizophrenia. Am J Psychiatry 1993;150:59-65.
44. Thaker G. Kirkpatrick B. Buchanan RW. Ellsbcrry R. Ijthti A, Tamminga CA: Oculomotor abnormalities and their clinical correlates in schizophrenia. Psychopharmacol Bull 1989:25:491-497.
45. Ribcyre JM. Lesieur Ph, Varoquaux O. Dollfus S. Pays M, Petit M: A comparison of plasma homovanillic acid in the deficit and nondeficit subtypes of schizophrenia. Biol Psychiatry 1994:36:230-236.
46. Nibuya M. Kanba S. Sekiya U. Suzuki E, Matsuo Y, Kinoshita N, Shintani F. Yagi G, Asai M: Schizophrenic patients with deficit syndrome have higher plasma homovanillic acid concentrations and ventricular enlargement. Biol Psychiatry 1995:38:50-56.
47. Thibaut F. Ribeyrc JM. Dollfus S, Petit M: Plasma HVAand MHPG levels in deficit and non deficit subtypes of schizophrenia. Symp Deficit Syndrome (Communication), Baltimore. 1996.
48. Samson JA, Gurrera RJ, Nisenson L. Schidkraut JJ: Platelet monoamine oxydase activity and deficit syndrome schizophrenia. Psychiatry Res 1995:56:25-31.
49. Goldberg SC: Negative and deficit symptoms in schizophrenia do respond to neuroleptics. Schizophr Bull 1985; 11:453-456.
50. Brcier A, Buchanan RW. Kirkpatrick B. Davis OR, Irish D. Summerfelt A, Carpenter W: Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia. Am J Psychiatry 1994:151:20-26.
51. Buchanan RW. Carpenter WT, Kirkpatrick B, Bryant N, Bust illo J: Dopamine agents for the treatment of the negative symptoms of schizophrenia. Schizophr Res 1996:18:144.
52. Gottesman II: Schizophrenia genesis: The origin of madness. New York, Freeman, 1991.
53. Crow TJ: A continuum of psychosis, one human gene, and not much else the case for homogeneity. Schizophr Res 1995:17:135-145.